The activist shareholder seeks two more seats on Masimo’s board, after both candidates it nominated last spring were voted in.
Masimo faces another proxy challenge from Politan Capital Read More »
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx Pharmaceuticals”, the “Company”), a clinical-stage biopharmaceutical company, today announced its financial results for the quarter and year ended December 31, 2023 and provided a business update.
Carisma Therapeutics Inc. today reported financial results for the fourth quarter, and full year ended December 31, 2023, and provided a business update.
Vistagen today announced that it has enrolled the first patient in its PALISADE-3 Phase 3 trial of fasedienol, an investigational pherine candidate in development for the acute treatment of social anxiety disorder (SAD).
Incyte and CMS Announce Collaboration and License Agreement for Povorcitinib, an Oral JAK1 Inhibitor, in Mainland China, Hong Kong, Macau, Taiwan and Southeast Asia.
The new company includes 3M’s medical, dental, health IT and filtration products.
The company has developed a virtual reality surgical platform for training and assessment.
Osso VR to lay off 67 people at corporate headquarters Read More »
AquaBounty Technologies, Inc. (NASDAQ: AQB) (“AquaBounty” or the “Company”), a land-based aquaculture company utilizing technology to enhance productivity and sustainability, today announced the Company’s financial results for the fourth quarter and full year ended December 31, 2023.
AquaBounty Technologies Announces Fourth Quarter and Full Year 2023 Financial Results Read More »
Aculys Pharma, Inc. announces the appointment of Hidemasa Tanigaki as Chief Executive Officer and Representative Director, effective March 29th.
Aculys Pharma Announces Appointment of Hidemasa Tanigaki as New CEO Read More »
3M completed the planned spin-off of its health care business, which formally launches Solventum Corporation as an independent company.
